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ABSTRACT
Background and aims Previous studies have shown that prescription opioid use ismore common in socio-economically
disadvantaged communities in the United States. This study examined the area and individual-level determinants of pre-
scription opioid use in Finland during the period 1995–2016.Design Logistic regression analysis using nation-wide data
on filled opioid-related prescriptions dispensed at Finnish pharmacies and covered by National Health Insurance. Opioid
consumption was linked, using personal identification codes, to population-based data maintained by Statistics Finland,
which records individual background and area-level characteristics. Setting and participants Working-age population
aged between 15 and 64 years in Finland during the periods 1995–2007 (n = 4315409) and 2009–16 (n = 4116992).
Measurements Annual prescription opioid use was measured using defined daily doses (DDD) and whether people used
opioids during a year. Findings Prescription opioid use increased in Finland from 1995 to 2016 (from less than 1 to 7%),
but the increase was explained by the change in the treatment of codeine-based opioids in National Health Insurance. The
area-level unemployment rate was positively correlated with the share of opioid users at the municipal level (r = 0.36;
P < 0.001). In comparison with being employed, being outside the labour force was associated with increased opioid
use in 1995–2007 [odds ratio (OR) = 2.22, 95% confidence interval (CI) = 2.10–2.36] and non-codeine opioid use in
2009–16 (OR = 2.16, 95% CI = 2.06–2.27), but not with codeine opioid use in 2009–16. Conclusions Prescription
opioid use in Finland appears to be more common among low socio-economic status people, similar to the United
States and the United Kingdom.
Keywords Codeine, Finland, opioid use, opioids, population-based, prescription drugs, prevalence, socio-economic
status.
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INTRODUCTION
The use of prescription opioids has increased dramatically
in the United States during the past few decades and has
currently reached epidemic proportions. Although the
prevalence of opioid prescriptions has decreased in the
United States since 2010 [1], the misuse and
non-medical use of opioids remain a major public health
and policy concern [2,3]. While the use of opioids has also
increased in many European countries [4,5], a similar
trend has not been observed in the Scandinavian countries
where the use of opioids has remained stable or decreased
[6–8]. Recent analyses suggest that, in the United States,
prescriptions of opioids and prescription opioid overdoses
are more common among socio-economically disadvan-
taged communities that suffer from higher rates of unem-
ployment, lower educational attainment and high levels
of uninsured people [1,9]. While studies from the United
Kingdom present a similar picture [10,11], a recent study
from Sweden suggests that older women, especially those
living alone, have higher rates of prescription opioid use
[12]. However, there is a lack of population-based studies
which investigate these issues combining both individual
and area-level information.
In the present study, we examined how demographic
and socio-economic factors were related to prescription
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opioid use among the working-age population in Finland
during the period 1995–2016. We used nation-wide
population-based data to document the individual-level
patterns of prescription opioid use and characteristics of
the regions where patients live. This information is useful
in order to better select demographic characteristics and
geographic areas for possible policy intervention. From
the prescription opioids, we differentiated codeine-based
opioids from other opioids, as they were included in 2008




The primary administrative data were from the Social
Insurance Institution containing filled opioid-related pre-
scriptions dispensed at Finnish pharmacies during the pe-
riod 1995–2016. Opioids cover the World Health
Organization (WHO)’s anatomical therapeutic chemical
(ATC) classification system codes beginning with ‘N02A’
(strong opiate-type analgesics and analgesics with similar
structure or action). The data contained patient-level pre-
scriptions reimbursed under NHI. People may have reim-
bursed opioid prescriptions multiple times within the
same year.
The prescription register (PR)was linked using personal
identification codes to population-based data, maintained
by Statistics Finland, to obtain information on individual
background characteristics, including education level, la-
bour market status and parental socio-economic status
(SES) during the period 1995–2016. The analysis of opioid
use was restricted to the working-age population aged be-
tween 15 and 64 years. The data covered approximately
3.3–3.5 million people annually.
Individual-level measures
In the analysis, opioid use was primarily defined aswhether
an individual was using prescription opioids during the
year (i.e. at least one reimbursed opioid prescription).
Additionally, prescription opioid use was measured as
defined daily doses (DDD) [13]. It provides a fixed unit of
measurement that accounts for the differences in package
size and strength, making comparisons possible between
population groups.
The models included the following individual-level co-
variates. Age, gender and marital status (indicating
whether an individual is married or in a registered partner-
ship) were obtained from Statistics Finland’s longitudinal
census files. Annual employment status (employed, unem-
ployed or outside the labour force, including students,
pensioners and housewives and house-husbands, mea-
sured during the last week of each year) originates from
the Finnish longitudinal employment statistics. The
highest completed education for both the individual and
parents is based on the Register of Completed Education
and Degrees, which is also maintained by Statistics
Finland. Parental education was included as an additional
measure of the individual’s SES, because parental SES may
differ considerably from the individual’s own SES
(measured by education and labour market status).
Area-level measures
The municipal-level unemployment rate (the number of
municipalities = 313) was computed as the ratio of unem-
ployed people (during the last week of each year) to the la-
bour force aged between 15 and 64 years in each
municipality.
Statistical analyses
The present study analyses were not pre-registered, and
thus the findings should be considered exploratory. The
preliminary analysis of the annual data from the PR indi-
cated that there was a noticeable increase in prescription
opioid use in 2008. The reason for this was that
codeine-based medicines (most popular brand name:
Panacod) were added to the list of reimbursed medicines
covered by the NHI in 2008 (ATC codes: N02AA59 and
N02AJ06). Therefore, we conducted all analyses separately
for 1995–2007 (n = 4315409) and 2009–16
(n = 4116992) and examined the use of codeine and
other opioids separately.
The associations between prescription opioid use and
individual-level characteristics were examined using logis-
tic regression models. The results were reported as odds
ratios (ORs) with 95% confidence intervals (CIs). CIs were
based on standard errors that have been clustered at the
municipality level. Descriptive patterns at the regional level
were investigated by aggregating individual-level data to
the municipality level, and then calculating the annual
share of people with opioid prescriptions for each munici-
pality. As there were very few missing data (fewer than
1%), all people with missing data were omitted from the
analyses. Stata version 15.1 (Stata Corp, College Station,
TX, USA) was used for all analyses.
RESULTS
Although prescription opioid use increased in Finland
during the period 1995–2016 (from less than 1 to 7%),
this increase was explained by the inclusion of
codeine-based opioids to the list of reimbursed medicines
(Supporting information, Fig. S1). The use of other opioids
than codeine remained stable. In codeine use, there was
even a slight decrease between 2012 and 2016.
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Table 1 Descriptive statistics of the study samples.



































15–24 years 20.6 0.3 20.5 3.3 2.9 0.6 3.0 2.9 0.2
25–34 years 19.3 0.9 19.7 6.3 5.3 1.4 5.4 5.3 0.6
35–44 years 21.9 1.4 19.0 8.0 6.5 2.1 6.6 6.5 0.7
45–54 years 22.6 2.0 21.2 9.3 7.4 2.7 7.4 7.4 0.8
55–64 years 15.6 2.5 19.6 10.1 7.7 3.3 7.6 7.7 0.7
Male 50.5 1.4 50.5 7.2 5.7 2.1 5.8 5.7 0.7
Female 49.5 1.3 49.3 7.6 6.3 2.0 6.3 6.3 0.6
Marital status
Married 46.3 1.6 41.8 8.4 6.8 2.3 6.8 6.8 0.7
Not married 53.7 1.2 58.2 6.6 5.4 1.8 5.5 5.4 0.6
Employment status
Working 62.7 1.1 65.0 7.5 6.3 1.7 6.3 6.3 0.5
Unemployed 9.7 1.3 9.0 7.7 6.0 2.4 6.4 6.0 1.1
Outside labour
force









30.8 1.6 34.1 8.9 7.1 2.5 7.3 7.1 0.9
High school 8.6 0.6 8.7 5.0 4.3 1.0 4.4 4.3 0.5













21.3 1.0 27.7 7.4 6.0 1.9 6.4 6.0 1.0
High school or
more







1.4 7.4 6.0 2.1 6.0 6.0 0.8
Mean opioids
DDDe for users
51.7 53.1 41.9 70.6 1.4 41.9 19.0
(Continues)
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Descriptive statistics of the study participants for the
periods 1995–2007 and 2009–16, together with the
changes between periods, are reported in Table 1. Five im-
portant patterns stand out. First, the share of users in-
creases notably with age, which was largest for those
aged 55–64 years (10.1% in 2009–16). Secondly, the
share of codeine users was larger among employed people
(6.3%) than people outside the labour force (5.1%),
whereas the opposite was found for non-codeine opioid
use (1.7 versus 2.7%). Thirdly, prescription opioid use
was most common among those with vocational upper
secondary education (8.9%). Fourthly, the share of users
in terms of parental background was largest among those
with only compulsory education (9.6%). The increase in
the use of opioids between the two periods was also highest
among this group. Lastly, codeine use was more common
among women (6.3%) than men (5.7%) in 2009–16.
Next, we examined the potential regional variation in
prescription opioid use in 2016. We noted two observa-
tions. First, there was substantial variation in prescription
opioid use among the municipalities, and the use of opioids
was not concentrated in urban areas in Finland
(Supporting information, Fig. S2). Secondly, there was a
positive correlation (r = 0.36; P< 0.001) between the un-
employment rate and the share of users at the municipal
level (Supporting information, Fig. S3) indicating that, on
an average, municipalities with a higher unemployment
rate had more people with opioid prescriptions. A similar
positive correlation was also found for codeine use
(r = 0.29; P < 0.001) and non-codeine opioid use
(r = 0.34; P < 0.001).
The associations between background characteristics
with prescription opioid use are reported in Table 2. We
found four important patterns. First, in comparison to
employed people, being outside the labour force was asso-
ciated with increased opioid use in 1995–2007
(OR = 2.22, 95% CI = 2.10–2.36) and with
non-codeine opioid use in 2009–16 (OR = 2.16, 95%
CI = 2.06–2.27). A similar association was not found
for codeine opioid use in 2009–16 (OR = 0.98, 95%
CI = 0.94–1.03). Secondly, high parental SES (high
school or more) was associated with lower odds of opioid
use in 1995–2007 (OR = 0.87, 95% CI = 0.85–0.89)
and with lower odds of non-codeine opioid use in
2009–16 (OR = 0.90, 95% CI = 0.88–0.92). A similar,
but weaker, association was also found for codeine opioid
use in 2009–16 (OR = 0.96, 95% CI = 0.95–0.97).
Thirdly, codeine opioid use was negatively associated with
age (lowest odds at ages 15–24, OR = 0.41, 95%
CI = 0.38–0.43; highest odds at ages 55–64,
OR = 1.19, 95% CI = 1.16–1.22 in 2009–16). Fourthly,
once we adjusted the individual-level background charac-
teristics and region and time fixed effects, the
municipal-level unemployment rate was no longer signif-
icantly associated with opioid use in any of the four
models.
DISCUSSION
The present study, using nation-wide population-based
data from Finland, shows that prescription opioid use was
most common among people aged 55–64 years or those
who had parents with low SES. Non-codeine opioid use
was more common among those people who were outside
the labour force compared to the employed, whereas the
opposite was found for codeine use. These findings indicate
that there are socio-economic differences between
non-codeine and codeine opioid use. The area-level unem-
ployment rate was positively correlated with the share of
opioid users at the municipal level.
These patterns are in accordance with analyses from
the United States and United Kingdom, where the use of
opioids is much higher in more socio-economically de-
prived areas [1,9,11], and with a Swedish study
Table 1. (Continued)








































45124 593 28059 740
aAverage annual group share during the observation period; baverage annual share of opioid users (%) within the subsample of people during the observation
period; cnon-codeine opioid users may also use codeine, and vice versa, and therefore columns (5) and (6) do not sum to (4); dthe share of prescription codeine
users is negligible during the first period 1995–2007; edefined daily dose (DDD) is defined by the World Health Organization as the assumed average main-
tenance dose per day for a drug used for its main indication in adults [13].
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demonstrating socio-economic differences in opioid use
[12]. Women have been reported to use more opioids in
the United States [14], which is in accordance with our
finding that codeine use was more common among
women. Although an increase in opioid use in Europe
has also been shown [4,5], our results are in line with
other Scandinavian countries where the use of opioids
has remained somewhat stable or even decreased in the
2010s [6–8]. To the best of our knowledge, the present
study is the first to show how socio-economic factors are
partially differently related to codeine and non-codeine opi-
oid use in a Scandinavian country.
Limitations
The main limitation of the present study is that the ad-
ministrative data included filled prescriptions that were
purchased from Finnish pharmacies and were covered
by NHI. Thus, the present results did not cover all
instances of opioid use. In particular, we did not assess
illicit opioid use. Secondly, we used information on filled
prescriptions, but there is a possibility that some patients
may not consume their medication as implied by filled
prescriptions. Thirdly, adults older than 64 years were
not included in the present study. Thus, the present
results are not generalizable to older adults. Recent
reports from the United States have demonstrated
high opioid use among older adults [3]. It remains
Table 2 The association between background characteristics and prescription opioid use.
1995–2007, any opioid 2009–16, any opioid 2009–16, codeine 2009–16, non-codeine opioids
(1) OR (95% CI) (2) OR (95% CI) (3) OR (95% CI) (4) OR (95% CI)
Demographic variables
15–24 years 0.15 (0.14–0.16) 0.35 (0.32–0.38) 0.41 (0.38–0.43) 0.16 (0.15–0.17)
25–34 years 0.62 (0.61–0.64) 0.77 (0.76–0.78) 0.80 (0.79–0.81) 0.64 (0.62–0.66)
35–44 years Ref Ref Ref Ref
45–54 years 1.29 (1.25–1.32) 1.15 (1.13–1.16) 1.12 (1.10–1.13) 1.23 (1.20–1.26)
55–64 years 1.14 (1.03–1.26) 1.21 (1.17–1.25) 1.19 (1.16–1.22) 1.19 (1.12–1.27)
Male 1.08 (1.03–1.13) 0.91 (0.89–0.92) 0.87 (0.86–0.89) 1.02 (1.00–1.04)
Female Ref Ref Ref Ref
Marital status
Married 1.01 (0.97–1.07) 1.02 (1.01–1.03) 1.02 (1.01–1.04) 1.02 (1.00–1.04)
Not married Ref Ref Ref Ref
Employment status
Working Ref Ref Ref Ref
Unemployed 1.16 (1.09–1.23) 1.01 (0.99–1.02) 0.94 (0.92–0.95) 1.34 (1.31–1.37)
Outside labour force 2.22 (2.10–2.36) 1.17 (1.11–1.23) 0.98 (0.94–1.03) 2.16 (2.06–2.27)
Highest education
Only compulsory education Ref Ref Ref Ref
Vocational upper secondary 1.00 (0.98–1.02) 1.04 (1.03–1.04) 1.04 (1.03–1.05) 0.97 (0.96–0.99)
High school 0.68 (0.66–0.70) 0.82 (0.79–0.84) 0.84 (0.82–0.87) 0.66 (0.63–0.69)
Tertiary 0.68 (0.64–0.73) 0.71 (0.70–0.73) 0.73 (0.72–0.74) 0.61 (0.60–0.63)
Parents’ highest education
Missing parental information 1.08 (1.00–1.15) 0.67 (0.63–0.71) 0.67 (0.63–0.71) 0.65 (0.60–0.70)
Only compulsory education Ref Ref Ref Ref
Vocational upper secondary 0.99 (0.98–1.00) 1.04 (1.03–1.04) 1.03 (1.03–1.04) 1.05 (1.04–1.07)
High school or more 0.87 (0.85–0.89) 0.95 (0.94–0.95) 0.96 (0.95–0.97) 0.90 (0.88–0.92)
Area-level measure
Municipal-level unemployment rate 1.07 (0.67–1.73) 1.23 (0.71–2.14) 1.34 (0.75–2.38) 0.97 (0.47–2.00)
Number of people 4 315409 4 116 992 4 108 510 4 092 048
Number of person-year observations 45124 593 28059740 27656333 26551 859
Ref = reference group; OR = odds ratio; CI = confidence interval, which is based on standard errors that have been clustered at the municipality level; results
are based on logistic regression models that account for region fixed effects (20 regions) and year fixed effects.
174 Petri Böckerman et al.
© 2020 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction Addiction, 116, 170–175
unclear whether the situation is similar in Finland.
Fourthly, our register data do not contain information
on cancer or non-cancer pain, which probably affects
opioid use.
CONCLUSIONS
In Finland, prescription opioid use increased from 1995 to
2016, but the increase was explained by the change in the
treatment of codeine-based opioids in NHI. Prescription
opioid use was more common among low socio-economic
status people. Thus, opioid use in Finland resembles the
patterns in the United States and United Kingdom, with a
concentration of use in socio-economically disadvantaged
groups. These patterns prevail, despite the fact that the
United States and United Kingdom have different health
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Figure S1 The share of people with opioid prescriptions an-
nually in 1995–2016. Sample: Working-age population
aged between 15 and 64 years. Notes: Dashed line indi-
cates the share of population using codeine-based medi-
cines, and dotted line indicates the share of population
using non-codeine opioids during the given year. Solid line
indicates the share of population using any opioids during
the given year.
Figure S2 The share of people with opioid prescriptions by
municipality in 2016. Notes: Population aged between
15 and 64 years. Data are shown in eight intervals.
Figure S3 The share of people with opioid prescriptions by
municipality and the unemployment rate by municipality
in 2016. Notes: Pearson’s correlation coefficient r = 0.36
(P < 0.001). The corresponding correlation coefficient for
codeine use is 0.29 (P< 0.001) and for non-codeine opioid
use 0.34 (P < 0.001), respectively.
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